Hip protectors: recommendations for conducting clinical trials—an international consensus statement (part II)

Introduction While hip protectors are effective in some clinical trials, many, including all in community settings, have been unable to demonstrate effectiveness. This is due partly to differences in the design and analysis. The aim of this report is to develop recommendations for subsequent clinica...

Full description

Saved in:
Bibliographic Details
Published in:Osteoporosis international 2010, Vol.21 (1), p.1-10
Main Authors: Cameron, I. D, Robinovitch, S, Birge, S, Kannus, P, Khan, K, Lauritzen, J, Howland, J, Evans, S, Minns, J, Laing, A, Cripton, P, Derler, S, Plant, D, Kiel, D. P
Format: Article
Language:English
Subjects:
Accidental Falls
Biological and medical sciences
Biomechanics
Clinical trials
Consensus Statement
Diseases of the osteoarticular system
Endocrinology
Fractures
Hip Fractures - etiology
Hip Fractures - prevention & control
Hip joint
Humans
Injuries of the limb. Injuries of the spine
Medical sciences
Medicine
Medicine & Public Health
Orthopedics
Osteoporosis
Osteoporosis. Osteomalacia. Paget disease
Personal protective equipment
Product testing
Protective Devices
Randomized Controlled Trials as Topic - methods
Research Design
Rheumatology
Traumas. Diseases due to physical agents
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Introduction While hip protectors are effective in some clinical trials, many, including all in community settings, have been unable to demonstrate effectiveness. This is due partly to differences in the design and analysis. The aim of this report is to develop recommendations for subsequent clinical research. Methods In November of 2007, the International Hip Protector Research Group met to address barriers to the clinical effectiveness of hip protectors. This paper represents a consensus statement from the group on recommended methods for conducting future clinical trials of hip protectors. Results and conclusions Consensus recommendations include the following: the use of a hip protector that has undergone adequate biomechanical testing, the use of sham hip protectors, the conduct of clinical trials in populations with annual hip fracture incidence of at least 3%, a run-in period with demonstration of adequate adherence, surveillance of falls and adherence, and the inclusion of economic analyses. Larger and more costly clinical trials are required to definitively investigate effectiveness of hip protectors.
ISSN:0937-941X
1433-2965
DOI:10.1007/s00198-009-1055-2